Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence

Global cancer statistics

Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Archives of Pathology & Laboratory Medicine · 2007 · 1.9K citations

Medicine, Oncology, Pathology +11

Pathology and genetics

J. N. Eble · Medical Entomology and Zoology · 2004 · 1.1K citations

Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer

Bradley J. Monk, Juan José Zarbá, Ana Oaknin et al. · Journal of Clinical Oncology · 2010 · 264 citations

Medicine, Oncology, Pharmacology +16

Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.

A.-M. F. Kersemaekers, G. J. Fleuren, Gemma G. Kenter et al. · PubMed · 1999 · 246 citations

Medicine, Molecular Biology, Oncology +16